| Health / Medical Topics |
18F-MISO
A radioactive substance being studied as an imaging agent in head and neck cancers and other types of cancer. It binds to large molecules in tumor cells that have a low level of oxygen. Radiation given off by 18F-MISO is detected by a PET scan. The amount of 18F-MISO in the tumor may help decide the best treatment and help predict whether the cancer will come back after treatment. 18F-MISO is a type of radioimaging agent. Also called 18F-fluoromisonidazole and FMISO. (NCI Dictionary)
YOU MAY ALSO LIKE
A radiotracer containing a pegylated dimeric Arg-Gly-Asp (RGD) peptide (NH2-mini-PEG-E[c(RGDyK)]2 or PRGD2) radiolabeled with fluorine 18F-fluorobenzoate (18F-FB), with potential alphaVbeta3 integrin imaging…
A radioactive substance being studied in PET imaging to detect certain types of cancer. 18F-FMCH gets taken up by cells in…
A radioactive substance being studied in the diagnosis of cancer. 18F-fluorothymidine is injected into the blood and builds up in cells that…
A radioactive substance being studied as an imaging agent in head and neck cancers and other types of cancer. It binds to…
A radioactive substance being studied in PET imaging to detect certain types of cancer. 18F-fluoromethylcholine gets taken up by cells in…
A radiofluorinated 2-nitroimidazole derivative with positron-emitting radioisotope activity. Upon administration, 18F-fluoroazomycin arabinoside is reduced under hypoxic conditions in the tumor microenvironment to…
